GENEVA, March 8 -- RIGERNA THERAPEUTICS (SUZHOU) CO., LTD. (Room B908, 9th Floor, Building B1, Phase I, Biomedical Industrial Park, No. 218, Xinghu Street, Suzhou Industrial ParkSuzhou, Jiangsu 215128), 苏州炫景生物科技有限公司 (中国江苏省苏州市苏州工业园区星湖街218号生物医药产业园一期B1栋9层B908室) filed a patent application (PCT/CN2023/116571) for "DOUBLE-STRANDED OLIGONUCLEOTIDE AND CONJUGATE FOR INHIBITING EXPRESSION OF C3 GENES, AND USES THEREOF" on Sep 01, 2023. With publication no. WO/2...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.